Suchergebnisse - "Edwards, Holly"

PubPharm (104)

1

The Imipridone ONC213 Targets α-Ketoglutarate Dehydrogenase to Induce Mitochondrial Stress and Suppress Oxidative Phosphorylation in Acute Myeloid Leukemia

enthalten in: Cancer research | 2024

von Su, Y. | Carter, J. | Li, X. | +31

2

Panobinostat sensitizes AraC-resistant AML cells to the combination of azacitidine and venetoclax

enthalten in: Biochemical pharmacology | 2024

von Zhao, J. | Wu, S. | Wang, D. | +9

3

Enhancing anti-AML activity of venetoclax by isoflavone ME-344 through suppression of OXPHOS and/or purine biosynthesis in vitro

enthalten in: Biochemical pharmacology | 2024

von Hurrish, K. | Su, Y. | Patel, S. | +26

UpdateOf: Res Sq. 2023 Apr 28;:. - PMID 37162954

4

Acquired resistance to venetoclax plus azacitidine in acute myeloid leukemia : In vitro models and mechanisms

enthalten in: Biochemical pharmacology | 2023

von Carter, J. | Su, Y. | Qiao, X. | +10

5

Curing childhood cancer the "Natural" Way : Nature as the source of chemotherapy agents

enthalten in: Biochemical pharmacology | 2023

von Al-Antary, E. | Gupte, A. | Carter, J. | +5

6

Enhancing anti-AML activity of venetoclax by isoflavone ME-344 through suppression of OXPHOS and purine biosynthesis

enthalten in: ResearchSquare.com | 2023

von Baran, N. | Hurrish, K. | Su, Y. | +24

7

Enhancing anti-AML activity of venetoclax by isoflavone ME-344 through suppression of OXPHOS and/or purine biosynthesis

enthalten in: Research square | 2023

von Hurrish, K. | Su, Y. | Patel, S. | +24

UpdateIn: Biochem Pharmacol. 2023 Dec 10;220:115981. - PMID 38081370

8

c-Myc plays a critical role in the antileukemic activity of the Mcl-1-selective inhibitor AZD5991 in acute myeloid leukemia

enthalten in: Apoptosis : an international journal on programmed cell death | 2022

von Liu, S. | Qiao, X. | Wu, S. | +8

9

Co-targeting of HDAC, PI3K, and Bcl-2 results in metabolic and transcriptional reprogramming and decreased mitochondrial function in acute myeloid leukemia

enthalten in: Biochemical pharmacology | 2022

von Hege Hurrish, K. | Qiao, X. | Li, X. | +13

10

Inhibition of Mcl-1 Synergistically Enhances the Antileukemic Activity of Gilteritinib and MRX-2843 in Preclinical Models of FLT3-Mutated Acute Myeloid Leukemia

enthalten in: Cells | 2022

von Wu, S. | Edwards, H. | Wang, D. | +7

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[11]